Synthetic peptides and non-peptidic molecules as probes of structure and function of Bcl-2 family proteins and modulators of apoptosis

Apoptosis

Volumn 6, Issue 6, 2001, Pages 453-462

  Liu, D ^a   Huang, Z ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Apoptosis; Bcl 2 family; Cancer; Caspases; Drug design; Mitochondria; Peptides; Structure and function

Indexed keywords

ANTIMYCIN A1; FAS ANTIGEN; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BCL-X PROTEIN; BINDING SITES; CELL DEATH; CELL SURVIVAL; DIMERIZATION; HUMANS; LIGANDS; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2; SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035181345     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012481406064     Document Type: Article

References (73)

1. Apoptosis in the pathogenesis and treatment of disease
2. Caspases: Enemies within
3. Mitochondria and apoptosis
4. Death receptors: Signaling and modulation
5. The Bcl-2 protein family: Arbiters of cell survival
6. Bcl-2 family: Regulators of cell death
7. Solution structure of the antiapoptotic protein Bcl-2
8. L, an inhibitor of programmed cell death
9. L. Implications for the function of the Bcl-2 protein family
10. Structure of Bax: Coregulation of dimer formation and intracellular localization
11. Solution structure of the proapoptotic molecule Bid: A structural basis for apoptotic agonists and antagonists
12. Solution structure of Bid, an intracellular amplifier of apoptotic signaling
13. L and Bcl-2, displaces Bax and promotes cell death
14. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
15. Bcl-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy
16. L-Bak peptide complex: Recognition between regulators of apoptosis
17. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis
18. L
19. Cleavage of Bid during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: A potential feedback loop for amplification of apoptosisassociated mitochondrial cyrochrome c release
20. Cleavage of Bid by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
21. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
22. Bcl-2 and Bax function independently to regulate cell death
23. L forms an ion channel in synthetic lipid membranes
24. Channel formation by antiapoptotic protein Bcl-2
25. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic Bcl-2
26. Inhibition of Bax channel-forming activity by Bcl-2
27. Ion channel activity of the BH3 only Bcl-2 family member, BID
28. Bcl-2 family: Life-or-death switch
29. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC
30. Bcl-2 and the regulation of programmed cell death
31. Bcl-2 antisense therapy in patients with non-Hodgkin lymphoma
32. Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
33. Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7
34. Bcl-2-family proteins: The role of the BH3 domain in apoptosis
35. L
36. L/Bad peptide complex formation from structure, mutagenesis, and biophysical studies
37. L proteins
38. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members
39. Regulation of apoptosis by BH3 domains in a cell-free system
40. Bax directly induces release of cytochrome c from isolated mitochondria
41. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria
42. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death
43. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4
44. Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse
45. Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1
46. p21WAFl-derived peptides linked to an internalization peptide inhibit human cancer cell growth
47. Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A
48. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain
49. Selective inhibition of growth factor-stimulated mitogenesis by a cell-permeable Grb2-binding peptide
50. Inhibition of FGF-stimulated phosphatidylinositol hydrolysis and neurite outgrowth by a cell-membrane permeable phosphopeptide
51. L function and induce apoptosis through cytochrome c-independent activation of caspases
52. Inhibition of IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat by a novel peptide inhibitor of protein kinase C
53. A peptide-based protein-tyrosine phosphatase inhibitor specifically enhances insulin receptor function in intact cells
54. Cell permeable Bcl-2 binding peptides: A chemical approach to apotosis induction in tumor cells
55. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein
56. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent
57. In vivo protein transduction: Delivery of a biologically active protein into the mouse
58. Novel antitumor antibiotics, tetrocarcins
59. Tetrocarcin A inhibits mitochondrial functions of Bcl-2 and suppresses its anti-apoptotic activity
60. L
61. Isolation, structure and properties of antimycin A
62. Structural factors of antimycin A molecule required for inhibitory action
63. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax
64. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions
65. Bik, a novel deathinducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins
66. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2
67. Structural chemistry and therapeutic intervention of protein-protein interaction in immune response, HIV entry and apoptosis
68. Structure-based discovery of a novel organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells
69. Reactions of salicylaldehydes with alkyl cyanoacetates on the surface of solid catalysts: Syntheses of 4H-chromene derivatives
70. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax
71. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2
72. Bcl-2 targets the protein kinase Raf-1 to mitochondria